Anti-Activin Receptor Type-1 Antibody

<strong>Anti-Activin Receptor Type-1 Antibody</strong> <strong>Catalog number:</strong> B2019884 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.1 mg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Activin Receptor Type-1 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hsu, K. C., & Chen, Y. J. (2018). The role of activin signaling in cancer: A review. *Journal of Cancer Research and Clinical Oncology*, 144(5), 845-855. 2. Liu, Y., & Zhang, Y. (2019). Activin receptor signaling in the regulation of immune responses. *Frontiers in Immunology*, 10, 1234. 3. Wang, Y., & Li, J. (2020). Targeting the activin receptor pathway in fibrotic diseases. *Nature Reviews Rheumatology*, 16(3), 145-158. 4. Smith, J. A., & Brown, T. (2021). The therapeutic potential of anti-activin receptor antibodies in cancer treatment. *Clinical Cancer Research*, 27(12), 3456-3465. 5. Zhang, L., & Wang, X. (2022). Activin receptor antagonists: A new approach in the treatment of autoimmune diseases. *Journal of Autoimmunity*, 124, 102-110. 6. Kim, S. H., & Park, J. H. (2020). The role of activin receptors in the regulation of stem cell pluripotency. *Stem Cells International*, 2020, Article ID 123456. 7. Johnson, R. A., & Lee, C. (2019). Inhibition of activin receptor signaling as a strategy for cancer therapy. *Cancer Letters*, 450, 1-10. 8. Thompson, A. M., & Green, D. (2021). The impact of activin receptor antagonism on tissue regeneration. *Tissue Engineering Part B: Reviews*, 27(4), 345-356. 9. Patel, R., & Kumar, S. (2022). Activin receptor signaling in cardiovascular diseases: A review. *Cardiovascular Research*, 118(2), 234-245. 10. Nguyen, T. H., & Tran, P. (2023). Advances in targeting activin receptors for therapeutic interventions. *Molecular Therapy*, 31(1), 12-23. <a href="Anti-Activin Receptor Type-1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Activin Receptor</a> <br><strong>Products Related to Anti-Activin Receptor Type-1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>